NKTR Market Cap History
Below is a table of the NKTR market cap history going back to 2/26/2010:

Date NKTR Market Cap
2/26/20101.16B
4/30/20101.31B
7/23/20101.21B
10/31/20101.37B
2/25/20111.11B
4/25/20111.12B
8/1/2011716.26M
10/31/2011620.19M
2/24/2012799.42M
4/27/2012901.99M
8/6/2012975.58M
11/5/20121.04B
2/21/20131.04B
4/30/20131.25B
8/1/20131.47B
10/31/20131.10B
2/20/20141.74B
4/30/20141.49B
7/24/20141.40B
10/30/20141.80B
2/20/20151.79B
4/23/20151.45B
7/30/20151.63B
10/29/20151.59B
2/19/20161.55B
4/27/20162.21B
7/28/20162.20B
10/27/20161.87B
2/24/20172.07B
5/4/20172.88B
8/3/20173.13B
11/2/20173.71B
2/22/201814.20B
5/3/201814.18B
8/3/20189.30B
11/1/20187.04B
2/22/20196.97B
5/1/20195.52B
8/1/20195.47B

Also see: NKTR Shares Outstanding History
and NKTR YTD Return
NKTR Historical Market Cap:
+17.87% CAGR
NKTR Historical Market Cap: +17.87% CAGR

Mouse over chart for data details
2/26/2010 ...8/1/2019
Nektar Therapeutics is a research-based biopharmaceutical company. Co.'s proprietary drugs and drug candidates that have either received regulatory approval or are being developed by Co. or in collaboration with other pharmaceutical companies or independent investigators include: ONZEALD™, a topoisomerase I inhibitor targeted for advanced metastatic breast cancer in patients with brain metastases; NKTR-181, an orally-available mu-opioid analgesic molecule for moderate to severe chronic pain; NKTR-214, a CD122-biased immune-stimulatory cytokine targeted for oncology; NKTR-358 for autoimmune disease; NKTR-262 targeted for solid tumors; and NKTR-255 targeted for immuno-oncology. We show 39 historical shares outstanding datapoints in our NKTR shares outstanding history coverage, used to compute NKTR market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing NKTR market cap history over the course of time is important for investors interested in comparing NKTR's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of NKTR versus a peer is one thing; comparing NKTR market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like NKTR can fluctuate over the course of history. With this page we aim to empower investors researching NKTR by allowing them to research the NKTR market cap history.
Quotes delayed 20 minutes
Get Free SEC filing alerts for NKTR:
NKTR SEC Filing Email Alerts ServiceExternal link
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Nektar Therapeutics (NKTR) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

NLNK Market Cap History
NOVN Market Cap History
NSTG Market Cap History
NTLA Market Cap History
NTRA Market Cap History
NTRP Market Cap History
NURO Market Cap History
NUVA Market Cap History
NVAX Market Cap History
NVIV Market Cap History
More Healthcare companies »

 

NKTR Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2019, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.